MSJCX Mutual Fund

MSJCX Mutual Fund (Global Endurance Portfolio - Class C) is managed by Morgan Stanley Investment Management. MSJCX expense ratio is 2.10%, holding 31 positions across sectors including Health Care, Materials, Consumer Discretionary. Inception date: 2018-12-31.

MSJCX performance shows a YTD return of 0.05%. The 1-year return is 3.82% and the 5-year return is -7.15%.

MSJCX top holdings include Victoria Plc (19.1%), Roivant Sciences Ltd. Common Shares (7.3%), Arbutus Biopharma Corp. (5.5%), Immunovant Inc (4.9%), Qxo, Inc. (4.8%). Go to all MSJCX holdings, MSJCX sectors, or MSJCX dividends.

MSJCX can be compared against other funds. Use MSJCX overlap to find shared positions, or MSJCX vs another fund for a side-by-side view. MSJCX alternatives are available via the screener, along with tax-loss harvesting opportunities.